Could Bordetella pertussis vaccine protect against coronavirus COVID-19?

Usama M. Alkholy, Mohamed E. Salama, Hagar Mahmoud, Ahmed Taher, Khaled M. Elsayes

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

According to the World Health Organization (WHO), as of today, there are 2.165.500 confirmed cases of the novel coronavirus disease (COVID-19) and 145.705 deaths in over 185 countries. Unfortunately, despite the tremendous efforts to develop a vaccine initiated by various leading health institutions all over the world, it may be 18 months before a vaccine against the coronavirus is publicly available. We are proposing a theory about testing the use of the Bordetella pertussis vaccine to protect against COVID-19. We deliver this theory to the scientific community, aiming to raise the concern about it, and to provide us with support by realistic and experimental evidence.

Original languageEnglish (US)
Pages (from-to)803-805
Number of pages3
JournalJournal of Global Antimicrobial Resistance
Volume22
DOIs
StatePublished - Sep 2020

ASJC Scopus subject areas

  • Microbiology
  • Immunology and Allergy
  • Immunology
  • Microbiology (medical)

Fingerprint

Dive into the research topics of 'Could Bordetella pertussis vaccine protect against coronavirus COVID-19?'. Together they form a unique fingerprint.

Cite this